UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 300

Sortiert nach

Paclitaxel Versus Doxorubicin as First-Line Single-Agent Chemotherapy for Metastatic Breast Cancer: A European Organization for Research and Treatment of Cancer Randomized Study With Cross-Over

Journal of clinical oncology, 2000-02, Vol.18 (4), p.724-733

2000

Volltextzugriff (PDF)

The requirements of a specialist breast unit

European journal of cancer (1990), 2000-12, Vol.36 (18), p.2288-2293

EUSOMA

2000

Volltextzugriff (PDF)

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

European journal of cancer (1990), 2003-02, Vol.39 (3), p.309-316

2003

Volltextzugriff (PDF)

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group

Annals of oncology, 1994-07, Vol.5 (6), p.521

1994

Volltextzugriff (PDF)

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

European journal of cancer (1990), 2003-03, Vol.39 (5), p.614-621

2003

Volltextzugriff (PDF)

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion

British Journal of Cancer, 1999-04, Vol.80 (1-2), p.221-228

1999

Volltextzugriff (PDF)

A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer

Annals of oncology, 2003-03, Vol.14 (3), p.433-440

2003

Volltextzugriff (PDF)

Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1649-1655

1995

Volltextzugriff (PDF)

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer

British journal of cancer, 1998-06, Vol.77 (12), p.2257-2263

1998

Volltextzugriff (PDF)

Combined Treatment With Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: a Randomized Study

JNCI : Journal of the National Cancer Institute, 2000-06, Vol.92 (11), p.903-911

2000

Volltextzugriff (PDF)

Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck

Annals of oncology, 1996-10, Vol.7 (8), p.867-869

1996

Volltextzugriff (PDF)

Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study

Anti-cancer drugs, 1998-09, Vol.9 (8), p.675-683

1998

Volltextzugriff (PDF)

An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer

Annals of oncology, 1995-09, Vol.6 (7), p.673-677

1995

Volltextzugriff (PDF)

Mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer

European journal of cancer (1990), 1995-11, Vol.31 (12), p.2114-2115

1995

Volltextzugriff (PDF)

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group

British journal of cancer, 1998-06, Vol.77 (12), p.2257-2263

1998

Volltextzugriff (PDF)

Docetaxel is A Potent Cytotoxic Drug in the Treatment of Advanced Breast Cancer

Acta clinica belgica (English ed. Online), 1998-08, Vol.53 (4), p.264-269

1998

Volltextzugriff (PDF)

A phase II trial of 10-Ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck

Annals of oncology, 1992-03, Vol.3 (3), p.223-226

1992

Volltextzugriff (PDF)

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 1994-07, Vol.5 (6), p.521-526

1994

Volltextzugriff (PDF)

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients

European journal of cancer (1990), 2003-03, Vol.39 (5), p.614-621

2003

Volltextzugriff (PDF)

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

Cancer, 1987-09, Vol.60 (6), p.1173-1177

1987

Volltextzugriff (PDF)

Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU

European journal of cancer & clinical oncology, 1990, Vol.26 (7), p.857-857

1990

Volltextzugriff (PDF)

Treatment of operable breast cancer in the elderly

European journal of cancer (1990), 2003-02, Vol.39 (3), p.309-316

2003

Volltextzugriff (PDF)

Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-ARM randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)

Journal of steroid biochemistry and molecular biology, 1990-12, Vol.37 (6), p.1013-1019

1990

Volltextzugriff (PDF)

Locally advanced breast cancer (LABC): neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC)

European journal of cancer (1990), 1999-09, Vol.35, p.S208-S208

1999

Volltextzugriff (PDF)

Relevance of hydroxyproline excretion to bone metastasis in breast cancer

British journal of cancer, 1976-09, Vol.34 (3), p.279-285

1976

Volltextzugriff (PDF)

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(278)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Paclitaxel Versus Doxorubicin as First-Line Single-Agent Chemotherapy for Metastatic Breast Cancer: A European Organization for Research and Treatment of Cancer Randomized Study With Cross-Over

The requirements of a specialist breast unit

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion

A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer

Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer

Combined Treatment With Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: a Randomized Study

Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck

Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study

An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer

Mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group

Docetaxel is A Potent Cytotoxic Drug in the Treatment of Advanced Breast Cancer

A phase II trial of 10-Ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU

Treatment of operable breast cancer in the elderly

Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-ARM randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)

Locally advanced breast cancer (LABC): neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC)

Relevance of hydroxyproline excretion to bone metastasis in breast cancer

Suchergebnisse filtern